Try
Penumbra Inc.
PENUnited States
75 filed reports · 526 financial concepts · 0 earnings calls · 2 media appearances
Filed reports
75 reports · Sep 2015 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 100 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 33 | 4,956 | Sep 2015 to Jun 2026 |
| Current · 8-KSEC EDGAR | 31 | 100 | Dec 2015 to Sep 2025 |
| Annual · 10-KSEC EDGAR | 11 | 6,140 | Dec 2015 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 334 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 190 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 25, 2026 | 953 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 228 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 5, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 29, 2025 | 131 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 29, 2025 | 2 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | Apr 23, 2025 | 5 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 23, 2025 | 125 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 18, 2025 | 491 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Feb 18, 2025 | 7 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Oct 30, 2024 | 162 | Open |
Financial data
526 concepts · 11,196 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial516 concepts · 10,779 facts · Dec 2013 to Jul 2026
- Cost of revenue (US GAAP)63 · Dec 2013 to Jun 2026
- Gross profit (US GAAP)63 · Dec 2013 to Jun 2026
- Net income loss63 · Dec 2013 to Jun 2026
- Revenue63 · Dec 2013 to Jun 2026
- Allocated share based compensation expense61 · Dec 2013 to Jun 2026
- Cash and cash equivalents at carrying value61 · Dec 2013 to Jun 2026
- Comprehensive income net of tax61 · Dec 2013 to Jun 2026
- Depreciation depletion and amortization61 · Dec 2013 to Jun 2026
- Earnings per share basic61 · Dec 2013 to Jun 2026
- Earnings per share diluted61 · Dec 2013 to Jun 2026
- Income tax expense benefit61 · Dec 2013 to Jun 2026
- Inventory write down61 · Dec 2013 to Jun 2026
- Operating expenses (US GAAP)61 · Dec 2013 to Jun 2026
- Operating income loss61 · Dec 2013 to Jun 2026
- Other nonoperating income expense61 · Dec 2013 to Jun 2026
- Selling general and administrative expense61 · Dec 2013 to Jun 2026
- Weighted average number of diluted shares outstanding61 · Dec 2013 to Jun 2026
- Weighted average number of shares outstanding basic61 · Dec 2013 to Jun 2026
- Capital expenditures incurred but not yet paid60 · Dec 2013 to Jun 2026
- Increase decrease in accounts payable60 · Dec 2013 to Jun 2026
- Increase decrease in accounts receivable60 · Dec 2013 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities60 · Dec 2013 to Jun 2026
- Increase decrease in inventories60 · Dec 2013 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets60 · Dec 2013 to Jun 2026
Geography3 concepts · 178 facts · Dec 2013 to Jun 2026
- Revenue164 · Dec 2013 to Jun 2026
- United States13 · Dec 2015 to Dec 2025
- Revenue from contracts with customers (excluding tax)1 · Sep 2019
Product1 concepts · 139 facts · Dec 2013 to Jun 2026
- Revenue139 · Dec 2013 to Jun 2026
Guidance6 concepts · 100 facts · Mar 2016 to Nov 2025
- Revenue Guidance61 · Mar 2016 to Nov 2025
- Revenue Growth Guidance21 · Feb 2020 to Jul 2025
- Operating Margin Guidance8 · Feb 2024 to Apr 2025
- Gross Margin Guidance6 · Feb 2024 to Apr 2025
- Gross Margin Growth Guidance2 · Jul 2024
- Operating Margin Growth Guidance2 · Jul 2024
Segments
317 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographicalsrt:StatementGeographicalAxis4 members · 107 facts
- US52 · Dec 2016 to Jun 2026
- Other Non US31 · Dec 2016 to Sep 2025
- JP12 · Dec 2016 to Dec 2019
- Non Us12 · Dec 2018 to Jun 2026
Product or servicesrt:ProductOrServiceAxis5 members · 95 facts
- Neuro30 · Dec 2016 to Sep 2023
- Peripheral Vascular30 · Dec 2016 to Sep 2023
- Thrombectomy19 · Dec 2021 to Jun 2026
- Embolization And Access11 · Mar 2023 to Jun 2026
- Embolization5 · Dec 2021 to Dec 2025
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 71 facts
- US27 · Dec 2013 to Sep 2018
- JP22 · Dec 2013 to Sep 2018
- Other Non US22 · Dec 2013 to Sep 2018
Product or serviceus-gaap:ProductOrServiceAxis2 members · 44 facts
- Neuro22 · Dec 2013 to Sep 2018
- Peripheral Vascular22 · Dec 2013 to Sep 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary58 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary167 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes8 claims from 1 reports · Dec 2025
- Risk factors124 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
2 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Conference talks1 · Aug 2021
- Other appearances1 · Sep 2022
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.